Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis

Journal of Neuroscience

Volumn 24, Issue 50, 2004, Pages 11253-11263

  Dinis, Paulo ^a,e   Charrua, Ana ^a,b   Avelino, Antonio ^a,b   Yaqoob, Mohammed ^c   Bevan, Stuart ^c   Nagy, Istvan ^d   Cruz, Francisco ^a,e  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Novatis Inst for Medical Sciences   (United Kingdom)

^d CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^e HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Bladder; Capsaicin; Cyclophosphamide; Hyperalgesia; Primary sensory neuron; Resiniferatoxin

Indexed keywords

ANANDAMIDE; CAPSAZEPINE; RESINIFERATOXIN; RIMONABANT; VANILLOID RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; CYSTITIS; DRUG POTENCY; FEMALE; HYPERREFLEXIA; MICTURITION REFLEX; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL;

ACROLEIN; ANIMALS; ARACHIDONIC ACIDS; CAPSAICIN; CYCLOPHOSPHAMIDE; CYSTITIS; FEMALE; HYDROLYSIS; ION CHANNELS; PAIN; POLYUNSATURATED ALKAMIDES; POSTERIOR HORN CELLS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; REFLEX, ABNORMAL; TRPV CATION CHANNELS; URINARY BLADDER;

EID: 10644240899     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2657-04.2004     Document Type: Article

References (55)

1. Ahluwalia A, Maggi CA, Santicioli P, Lecci A, Giuliani S (1994) Characterization of the capsaicin-sensitive component of cyclophosphamide- induced inflammation in the rat urinary bladder. Br J Pharmacol 111:1017-1022.
2. Ahluwalia J, Urban L, Capogna M, Bevan S, Nagy I (2000) Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience 100:685-688.
3. Ahluwalia J, Yaqoob M, Urban L, Bevan S, Nagy I (2003a) Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J Neurochem 84:585-591.
4. Ahluwalia J, Urban L, Bevan S, Nagy I (2003b) Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur J Neurosci 17:2611-2618.
5. Akerman S, Kaube H, Goadsby PJ (2004) Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther 309:56-63.
6. Avelino A, Cruz F, Coimbra A (1999) Intravesical resiniferatoxin desensitizes rat bladder sensory fibres without causing intense noxious excitation. A c-fos study. Eur J Pharmacol 378:17-22.
7. Avelino A, Cruz C, Nagy I, Cruz F (2002) Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 109:787-798.
8. Avelino A, Dinis P, Charrua A, Nagy I, Yacoob M, Cruz F (2003) The endogenous TRPV1 ligand anandamide increases in the rat inflamed urinary bladder and may contribute to inflammatory pain. Soc Neurosci Abstr 29:608.3.
9. Bevan S, Hothi S, Hughes G, James IF, Rang HP, Shah K, Walpole CS, Yeats JC (1992) Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br J Pharmacol 107:544-552.
10. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816-824.
11. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288:306-313.
12. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, Chao MV, Julius D (2001) Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411:957-962.
13. Cox PJ (1979) Cyclophosphamide cystitis-identification of acroleine as the causative agent. Biochem Pharmacol 28:2045-2049.
14. Davis JB, Gray J, Gunthorpe MJ, Davey PT, Overend P, Harries MH, Latcham J, Clapham C, Atkinson K, Rance K, Grau E, Harper AJ, Pugh PL, Rogers DC, Bingham S, Sheardown SA (2000) Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405:183-187.
15. De Petrocellis L, Harrison S, Bisogno T, Tognetto M, Brandi I, Smith GD, Creminon C, Davis JB, Geppetti P, Di Marzo V (2001) The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 2001 77:1660-1663.
16. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
17. Di Marzo V, De Petrocellis L, Sepe N, Buono A (1996) Biosynthesis of anandamide and related acylethanolamides in mouse 1774 macrophages and N18 neuroblastoma cells. Biochem J 316:977-984.
18. Dinis P, Charrua A, Avelino A, Cruz F (2004) Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladders. BJU Int 94:153-157.
19. Evans RM, Scott RH, Ross RA (2004) Multiple actions of anandamide on neonatal rat cultured sensory neurones. Br J Pharmacol 141:1223-1233.
20. Garcia DE, Brown S, Hille B, Mackie K (1998) Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J Neurosci 18:2834-2841.
21. Gawa NR, Klionsky L, Qu Y, Shi L, Tamir R, Edenson S, Zhang TJ, Viswanadhan VN, Toth A, Pearce LV, Vanderah TW, Porreca F, Blumberg PM, Lile J, Sun Y, Wild K, Louis JC, Treanor JJ (2004) Molecular determinants of vanilloid sensitivity in TRPV1. J Biol Chem 279:20283-20295.
22. Giang DK, Cravatt BF (1997) Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci USA 94:2238-2242.
23. Guo A, Vulchanova L, Wang J, Li X, Elde R (1999) Immunocytochemical localization of the vanilloid receptor 1 (VRI): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci 11:946-958.
24. Hampson AI, Bornheim LM, Scanziani M, Yost CS, Gray AT, Hansen BM, Leonoudakis DJ, Bickler PE (1998) Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J Neurochem 70:671-676.
25. Huang CC, Chen YL, Lo SW, Hsu KS (2002) Activation of cAMP-dependent protein kinase suppresses the presynaptic cannabinoid inhibition of glutamatergic transmission at corticostriatal synapses. Mol Pharmacol 61:578-585.
26. Hunt SP, Mantyh PW (2001) The molecular dynamics of pain control. Nat Rev Neurosci 2:83-91.
27. Hunt SP, Pini A, Evan G (1987) Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 328:632-634.
28. Ishizuka O, Igawa Y, Mattiasson A, Andersson KE (1994) Capsaicin-induced bladder hyperactivity in normal conscious rats. J Urol 152:525-530.
29. Jonsson KO, Vandevoorde S, Lambert DM, Tiger G, Fowler CJ (2001) Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br J Pharmacol 133:1263-1275.
30. Jordt SE, Julius D (2002) Molecular basis for species-specific sensitivity to "hot" chili peppers. Cell 108:421-430.
31. Kimura T, Ohta T, Watanabe K, Yoshimura H, Yamamoto I (1998) Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor. Biol Pharm Bull 21:224-226.
32. Kollarik M, Undem BJ (2004) Activation of bronchopulmonary vagal afferent nerves with bradykinin, acid and vanilloid receptor agonists in wild-type and TRPV1-/- mice, J Physiol (Lond) 555:115-123.
33. Kuwae T, Shiota Y, Schmid PC, Krebsbach R, Schmid HO (1999) Biosynthesis and turnover of anandamide and other N-acylethanolamines in peritoneal macrophages. FEBS Lett 459:123-127.
34. Laird JM, Olivar T, Roza C, De Felipe C, Hunt SP, Cervero F (2000) Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene. Neuroscience 98:345-352.
35. Lecci A, Giuliani S, Meini S, Maggi CA (1994a) In vivo effects of neurokinin B on rat urinary bladder motility: involvement of tachykinin NK1 and NK2 receptors. Neuropeptides 27:53-62.
36. Lecci A, Giuliani S, Santicioli P, Maggi CA (1994b) Involvement of spinal tachykinin NK1 and NK2 receptors in detrusor hyperreflexia during chemical cystitis in anaesthetized rats. Eur J Pharmacol 259:129-135.
37. Linhart O, Obreja O, Kress M (2003) The inflammatory mediators serotonin, prostaglandin E2 and bradykinin evoke calcium influx in rat sensory neurons. Neuroscience 118:69-74.
38. Lu W, Haber SN (1992) In situ hybridization histochemistry: a new method for processing material stored for several years. Brain Res 578:155-160.
39. MacNaughton WK, Van Sickle MD, Keenan CM, Cushing K, Mackie K, Sharkey KA (2004) Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves. Am J Physiol Gastrointest Liver Physiol 286:G863-G871.
40. Malmberg AB, Brandon EP, Idzerda RL, Liu H, McKnight GS, Basbaum AI (1997) Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the type I regulatory subunit of cAMP-dependent protein kinase. J Neurosci 17:7462-7470.
41. McIntyre P, McLatchie LM, Chambers A, Phillips E, Clarke M, Savidge J, Toms C, Peacock M, Shah K, Winter J, Weerasakera N, Webb M, Rang HP, Bevan S, James IF (2001) Pharmacological differences between the human and rat vanilloid receptor 1 (VRI). Br J Pharmacol 132:1084-1094.
42. McVey DC, Schmid PC, Schmid H, Vigna SR (2003) Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1). J Pharmacol Exp Ther 304:713-722.
43. Premkumar LS, Ahern GP (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature 408:985-990.
44. Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM (2004) Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br J Pharmacol 141:1118-1130.
45. 1 receptors. Pain 75:111-119.
46. Roberts LA, Christie MJ, Connor M (2002) Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Br J Pharmacol 137:421-428.
47. Schmelz M, Schmid R, Handwerker HO, Torebjork HE (2000) Encoding of burning pain from capsaicin-treated human skin in two categories of unmyelinated nerve fibres. Brain 123:560-571.
48. Schmid HH (2000) Pathways and mechanisms of N- acylethanolaminebiosynthesis: can anandamide be generated selectively? Chem Phys Lipids 108:71-87.
49. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, Davis JB (2000) The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129:227-230.
50. Szallasi A (2002) Vaniltoid (capsaicin) receptors in health and disease. Am J Clin Pathol 118:110-121.
51. Szolcsanyi J (1977) A pharmacological approach to elucidation of the role of different nerve fibres and receptor endings in mediation of pain. J Physiol (Paris) 73:251-279.
52. Vizzard MA (2000) Alterations in spinal cord Fos protein expression induced by bladder stimulation following cystitis. Am J Physiol Regul Integr Comp Physiol 278:R1027-R1039.
53. Walpole CS, Bevan S, Bovermann G, Boelsterli JJ, Breckenridge R, Davies JW, Hughes GA, James I, Oberer L, Winter J, Wriglessworth R (1994) The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin. J Med Chem 37:1942-1954.
54. Zhou Y, Li GD, Zhao ZQ (2003) State-dependent phosphorylation of epsilon-isozyme of protein kinase C in adult rat dorsal root ganglia after inflammation and nerve injury. J Neurochem 85:571-580.
55. Zygmunt PM, Petersson J, Andersson D, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452-457.